Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 5/20 | 0.34 |
| ▸ | CNR2 | P34972 | 5/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17854872 | 0.90 | KDM4E (0.39) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL21359712 | 0.88 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL29372054 | 0.88 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL29351971 | 0.88 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17854883 | 0.88 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17854885 | 0.88 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL20429878 | 0.84 | IRAK4 (0.39) | IRAK4 | |
| SCHEMBL23888788 | 0.84 | ALDH1A1 (0.39) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17854876 | 0.82 | KDM4E (0.40) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL20550535 | 0.82 | KDM4E (0.40) | L3MBTL1ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10194659-B2 | Active compound combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-05 | — | — | US | disclosed |
| WO-2018046431-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-15 | — | — | WO | disclosed |
| US-20180035670-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-02-08 | — | — | US | disclosed |
| US-20180035670-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-02-08 | — | — | US | disclosed |
| US-20170349550-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-12-07 | — | — | US | disclosed |
| US-20170349550-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-12-07 | — | — | US | disclosed |
| US-20170339953-A1 | Active Compound Combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-30 | — | — | US | disclosed |
| US-20170339953-A1 | Active Compound Combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-30 | — | — | US | disclosed |
| US-20170325452-A1 | Active compound combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-16 | — | — | US | disclosed |
| US-20170325452-A1 | Active compound combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-16 | — | — | US | disclosed |
| WO-2016096944-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016097003-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016096849-A1 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170339953-A1 | Active Compound Combinations | NNMT, NNT, NQO2 | L3MBTL1 3856/4885ALDH1A1 1111/4885KDM4E 1832/4885 |
| US-20170349550-A1 | ACTIVE COMPOUND COMBINATIONS | NNMT, NNT, NQO2 | L3MBTL1 3856/4885ALDH1A1 1111/4885KDM4E 1832/4885 |
| US-20170325452-A1 | Active compound combinations | NNMT, NNT, NQO2 | L3MBTL1 3856/4885ALDH1A1 1111/4885KDM4E 1832/4885 |
| US-20180035670-A1 | ACTIVE COMPOUND COMBINATIONS | NNMT, NNT, NQO2 | L3MBTL1 3856/4885ALDH1A1 1111/4885KDM4E 1832/4885 |
| US-10194659-B2 | Active compound combinations | NNMT, NNT, NQO2 | L3MBTL1 3856/4885ALDH1A1 1111/4885KDM4E 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.